Traders should await the April 23 earnings call for material updates on varoglutamstat development, clinical progress, and 2025 financial performance. This release is purely administrative and contains no new investment-critical data.
Price Chart
Executive Summary
Vivoryon Therapeutics N.V. announced it will report full year 2025 financial results and business updates on April 23, 2026, via a public conference call and webcast. The press release provides no financial figures or material operational updates, serving only as a scheduling notice ahead of the earnings event.
Key Facts
- Vivoryon Therapeutics will report full year 2025 financial results on April 23, 2026
- The event will include a public conference call and webcast at 3:00 pm CEST / 9:00 am EDT
- No financial results, guidance, or material business updates were disclosed in this release
- The company reiterated forward-looking statement disclosures without providing new forecasts
Financial Impact
None disclosed
Risk Factors
- Forward-looking statements are subject to risks and uncertainties not detailed in this release
- No assurance of timely or successful development of varoglutamstat in diabetic kidney disease
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3274111 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 6, 2026 11w ago | Press Release | — | awaiting T+20 | — | — |
Jul 22, 2026 13w ago | Press Release | — | awaiting T+20 | — | — |
Jun 11, 2026 19w ago | Press Release | — | awaiting T+20 | — | — |
Jun 8, 2026 20w ago | Press Release | — | awaiting T+20 | — | — |
Apr 23, 2026 26w ago | Press Release | — | awaiting T+20 | — | — |
Apr 15, 2026 27w ago | Press Release | — | awaiting T+20 | — | — |
Apr 9, 2026 28w ago | Press Release | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers